We report seven patients with orthostatic tremor (OT) who were success
fully treated with the anticonvulsant gabapentin. Five of the patients
had been previously tried on clonazepam, the most commonly used drug
for OT, four without any benefit. The degree of improvement perceived
by the patients with gabapentin varied from 60-80% (mean 73%). The eff
ective dose of gabapentin ranged from 300-1800 mg/day (mean 1030 mg/da
y). The side effects were generally mild, transient, and dose-related.
Duration of response has so far ranged from 2-22 months (mean 11 mont
hs) with all patients still currently benefiting from gabapentin. We c
onclude that gabapentin may be an effective treatment for OT. Further
trials are indicated.